こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.
Breast cancer research and treatment·2025
Same author
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.
Nature communications·2025
Same author
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.
Nature communications·2024
Same author
Clinical efficacy and molecular mechanism of Chinese medicine in the treatment of autoimmune thyroiditis.
Journal of ethnopharmacology·2023
Same author
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nature communications·2021
Same journal
Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.
Frontiers in immunology·2026
Same journal
Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.
Frontiers in immunology·2026
Same journal
Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.
Frontiers in immunology·2026
Same journal
Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.
Frontiers in immunology·2026
Same journal
JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.
Frontiers in immunology·2026
Same journal
Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.
Frontiers in immunology·2026


